Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.64B | 3.42B | 3.39B | 2.48B | 2.10B | 2.31B |
Gross Profit | 2.23B | 1.84B | 1.98B | 2.12B | 2.09B | 1.66B |
EBITDA | 1.04B | 665.36M | 789.62M | 1.03B | 1.10B | 554.29M |
Net Income | 784.71M | 482.46M | 543.71M | 757.90M | 760.47M | 373.69M |
Balance Sheet | ||||||
Total Assets | 61.06B | 60.23B | 59.81B | 59.73B | 57.32B | 54.39B |
Cash, Cash Equivalents and Short-Term Investments | 10.62B | 10.53B | 12.20B | 11.62B | 13.86B | 12.10B |
Total Debt | 3.99B | 1.86B | 1.42B | 1.58B | 1.47B | 1.43B |
Total Liabilities | 55.42B | 54.97B | 54.67B | 55.26B | 52.02B | 49.23B |
Stockholders Equity | 5.62B | 5.24B | 5.12B | 4.48B | 5.30B | 5.16B |
Cash Flow | ||||||
Free Cash Flow | 710.57M | 764.88M | 1.25B | 1.16B | 768.06M | -13.07M |
Operating Cash Flow | 752.88M | 821.03M | 1.28B | 1.19B | 794.02M | 17.03M |
Investing Cash Flow | -923.97M | 177.57M | 323.97M | -4.86B | -4.38B | -2.35B |
Financing Cash Flow | 728.80M | -456.04M | -1.13B | 2.63B | 2.35B | 5.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | 6.83B | 13.26 | 9.08% | 2.88% | 18.01% | -12.51% | |
75 Outperform | 7.07B | 13.28 | 9.10% | 2.06% | -0.54% | 16.85% | |
72 Outperform | $6.95B | 9.61 | 14.71% | 3.11% | 11.52% | 220.78% | |
72 Outperform | 7.38B | 12.62 | 8.99% | 0.99% | 10.19% | 48.39% | |
72 Outperform | 6.22B | 11.94 | 6.88% | 3.56% | 3.65% | 20.33% | |
69 Neutral | 7.85B | 14.19 | 15.37% | 1.85% | 13.77% | 17.71% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On August 27, 2025, Synovus Financial Corp. and Pinnacle Financial Partners, Inc. announced a joint investor presentation regarding their planned business combination. The transaction aims to create a leading financial entity in the Southeast, but it faces potential risks including integration challenges, regulatory approvals, and market reactions, which could impact the expected benefits and performance of the combined company.
The most recent analyst rating on (SNV) stock is a Buy with a $57.00 price target. To see the full list of analyst forecasts on Synovus stock, see the SNV Stock Forecast page.